Hachioji, Japan

Satsuki Okuyama

This inventor holds 5 USPTO granted patents. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Company, Bristol-Myers Squibb. Active years: 1990-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satsuki Okuyama. Retrieved from https://idiyas.com/inventor/satsuki-okuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1990-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Satsuki Okuyama: Innovator in Pradimicin Derivatives

Introduction

Satsuki Okuyama is a prominent inventor based in Hachioji, Japan. She has made significant contributions to the field of chemistry, particularly in the development of pradimicin derivatives. With a total of 5 patents to her name, her work has garnered attention in both academic and industrial circles.

Latest Patents

Okuyama's latest patents focus on pradimic acids, amides, and novel pradimicin derivatives. The inventions relate to intermediates, pradimic acids, and pradimic acid amides characterized by specific chemical formulas. These innovations include processes for the preparation of these compounds, which have potential applications in pharmaceuticals.

Career Highlights

Throughout her career, Satsuki Okuyama has worked with notable companies, including Bristol-Myers Squibb Company. Her experience in the pharmaceutical industry has allowed her to develop her expertise in chemical compounds and their applications.

Collaborations

Okuyama has collaborated with esteemed colleagues such as Hajime Kamachi and Takaaki Okita. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Satsuki Okuyama's contributions to the field of chemistry, particularly in the area of pradimicin derivatives, highlight her role as a leading inventor. Her work continues to influence the pharmaceutical industry and advance scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…